.

Make Better Decisions

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Express Scripts
Farmers Insurance
McKinsey
Healthtrust
Julphar
Baxter
Federal Trade Commission
Argus Health
US Department of Justice
Fuji

Generated: September 22, 2017

DrugPatentWatch Database Preview

ERYPED Drug Profile

« Back to Dashboard

Which patents cover Eryped, and what generic Eryped alternatives are available?

Eryped is a drug marketed by Arbor Pharms Llc and Arbor Pharms Inc and is included in two NDAs.

The generic ingredient in ERYPED is erythromycin ethylsuccinate. There are ninety-eight drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the erythromycin ethylsuccinate profile page.

Summary for Tradename: ERYPED

Patents:0
Applicants:2
NDAs:2
Suppliers / Packagers: see list2
Bulk Api Vendors: see list21
Clinical Trials: see list1
Patent Applications: see list556
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:ERYPED at DailyMed

Pharmacology for Tradename: ERYPED

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Arbor Pharms Llc
ERYPED
erythromycin ethylsuccinate
GRANULE;ORAL050207-003Mar 30, 1987ABRXYesNo► Subscribe► Subscribe► Subscribe
Arbor Pharms Llc
ERYPED
erythromycin ethylsuccinate
GRANULE;ORAL050207-002Approved Prior to Jan 1, 1982RXYesYes► Subscribe► Subscribe► Subscribe
Arbor Pharms Inc
ERYPED
erythromycin ethylsuccinate
TABLET, CHEWABLE;ORAL050297-003Jul 5, 1988DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

UBS
Citi
Harvard Business School
Boehringer Ingelheim
Johnson and Johnson
Covington
Mallinckrodt
Accenture
Healthtrust
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot